Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?
Direct-to-consumer advertising (DTCA) of prescription drugs has been a heavily contested issue over the past decade, touching on several issues of responsibility facing the pharmaceutical industry. Much research has been conducted on DTCA, but hardly any studies have discussed this topic from a corp...
| Authors: | ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Springer Science + Business Media B. V
2010
|
| In: |
Journal of business ethics
Year: 2010, Volume: 94, Issue: 2, Pages: 211-224 |
| Further subjects: | B
direct-to-consumer-advertising (DTCA)
B consumer safety B Pharmaceutical Industry B Corporate social responsibility (CSR) |
| Online Access: |
Presumably Free Access Volltext (JSTOR) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000caa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1785638777 | ||
| 003 | DE-627 | ||
| 005 | 20230427062127.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220112s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10551-009-0257-z |2 doi | |
| 035 | |a (DE-627)1785638777 | ||
| 035 | |a (DE-599)KXP1785638777 | ||
| 035 | |a (DE-He213)s10551-009-0257-z-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a van de Pol, Pepijn K. C. |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility? |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Direct-to-consumer advertising (DTCA) of prescription drugs has been a heavily contested issue over the past decade, touching on several issues of responsibility facing the pharmaceutical industry. Much research has been conducted on DTCA, but hardly any studies have discussed this topic from a corporate social responsibility (CSR) perspective. In this article, we use several elements of CSR, emphasising consumer autonomy and safety, to analyse differences in DTCA practices within two different policy contexts, the United States of America and the European Union (EU). Doing so results in an alternative analysis of the struggle between proponents and opponents of DTCA from a CSR perspective, adding an alternative view on this debate. | ||
| 650 | 4 | |a consumer safety | |
| 650 | 4 | |a direct-to-consumer-advertising (DTCA) | |
| 650 | 4 | |a Pharmaceutical Industry | |
| 650 | 4 | |a Corporate social responsibility (CSR) | |
| 700 | 1 | |a de Bakker, Frank G. A. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of business ethics |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1982 |g 94(2010), 2, Seite 211-224 |h Online-Ressource |w (DE-627)270937129 |w (DE-600)1478688-6 |w (DE-576)121465284 |x 1573-0697 |7 nnns |
| 773 | 1 | 8 | |g volume:94 |g year:2010 |g number:2 |g pages:211-224 |
| 856 | |3 Volltext |u http://www.jstor.org/stable/40784597 |x JSTOR | ||
| 856 | |u https://research.vu.nl/files/2779849/250934.pdf |x unpaywall |z Vermutlich kostenfreier Zugang |h repository [oa repository (via OAI-PMH doi match)] | ||
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10551-009-0257-z |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 935 | |a mteo | ||
| 936 | u | w | |d 94 |j 2010 |e 2 |h 211-224 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4033697659 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1785638777 | ||
| LOK | |0 005 20220112043721 | ||
| LOK | |0 008 220112||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2021-12-30#4C658B1699D3BB12CF8A40F1CA64EEEC9DFE82D3 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 866 |x JSTOR#http://www.jstor.org/stable/40784597 | ||
| LOK | |0 935 |a ixzs |a ixrk |a zota | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||